Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2265791 | chr13:114178996 | T/C | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265792 | chr13:114179020 | T/A | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265793 | chr13:114179699 | A/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265794 | chr13:114180686 | A/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2266951 | chr22:21273441 | G/A | 2.07E-5 | 178 | 12.93 | 31.9 | 25.4 | KM Plot |
PCPG | rs2270459 | chr16:89979851 | A/C | 0.00014 | 178 | 3.17 | 20.2 | 25.92 | KM Plot |
PCPG | rs2270460 | chr16:89972416 | C/A | 0.000153 | 175 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs2275479 | chr1:36921227 | A/G | 7.84E-5 | 177 | 25.28 | 26.62 | 10.3 | KM Plot |
PCPG | rs2275480 | chr1:36921533 | A/G | 8.27E-5 | 176 | 25.4 | 26.62 | 10.3 | KM Plot |
PCPG | rs2276711 | chr3:196054004 | A/G | 0 | 178 | 1.7 | 24.17 | 25.77 | KM Plot |
PCPG | rs2278161 | chr18:72176083 | T/C | 3.59E-6 | 176 | 24.7 | 28.83 | 10.3 | KM Plot |
PCPG | rs2278162 | chr18:72175814 | A/G | 3.19E-6 | 177 | 24.7 | 27.33 | 10.3 | KM Plot |
PCPG | rs2278268 | chr16:87336838 | T/C | 9.37E-5 | 176 | 24.1 | 30.63 | 3.17 | KM Plot |
PCPG | rs2283564 | chr16:89815656 | T/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2283565 | chr16:89827556 | G/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |